Wedge Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-9,533
| Closed | -$786K | – | 567 |
|
|
2016
Q2 | $786K | Sell |
9,533
-1,623
| -15% | -$134K | 0.01% | 354 |
|
|
2016
Q1 | $847K | Sell |
11,156
-19
| -0.2% | -$1.44K | 0.01% | 338 |
|
|
2015
Q4 | $898K | Buy |
11,175
+900
| +9% | +$72.3K | 0.01% | 341 |
|
|
2015
Q3 | $653K | Buy |
10,275
+1,550
| +18% | +$98.5K | 0.01% | 395 |
|
|
2015
Q2 | $614K | Buy |
8,725
+2,125
| +32% | +$150K | 0.01% | 418 |
|
|
2015
Q1 | $523K | Buy |
6,600
+100
| +2% | +$7.92K | 0.01% | 440 |
|
|
2014
Q4 | $414K | Sell |
6,500
-900
| -12% | -$57.3K | ﹤0.01% | 467 |
|
|
2014
Q3 | $442K | Buy |
7,400
+875
| +13% | +$52.3K | ﹤0.01% | 460 |
|
|
2014
Q2 | $349K | Buy |
6,525
+3,000
| +85% | +$160K | ﹤0.01% | 479 |
|
|
2014
Q1 | $213K | Buy |
+3,525
| New | +$213K | ﹤0.01% | 483 |
|
|
2013
Q4 | – | Sell |
-5,000
| Closed | -$231K | – | 497 |
|
|
2013
Q3 | $231K | Sell |
5,000
-800
| -14% | -$37K | ﹤0.01% | 452 |
|
|
2013
Q2 | $238K | Buy |
+5,800
| New | +$238K | ﹤0.01% | 450 |
|